Alexey L. Margolin, Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU), sold 6,750 shares at $16.86 ($114K) on 2006-11-13, disclosed to the SEC on 2006-11-15.
Open-market sale of $114k ALTU by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 100 | $2K | 1.5% |
| 2 | $16.73 | 150 | $3K | 2.2% |
| 3 | $16.74 | 100 | $2K | 1.5% |
| 4 | $16.75 | 260 | $4K | 3.8% |
| 5 | $16.78 | 340 | $6K | 5.0% |
| 6 | $16.79 | 200 |
| $3K |
| 2.9% |
| 7 | $16.80 | 200 | $3K | 2.9% |
| 8 | $16.81 | 200 | $3K | 2.9% |
| 9 | $16.84 | 350 | $6K | 5.2% |
| 10 | $16.85 | 250 | $4K | 3.7% |
| 11 | $16.86 | 100 | $2K | 1.5% |
| 12 | $16.87 | 100 | $2K | 1.5% |
| 13 | $16.88 | 300 | $5K | 4.4% |
| 14 | $16.89 | 100 | $2K | 1.5% |
| 15 | $16.92 | 100 | $2K | 1.5% |
| 16 | $16.94 | 671 | $11K | 9.9% |
| 17 | $16.96 | 400 | $7K | 5.9% |
| 18 | $16.99 | 100 | $2K | 1.5% |
| 19 | $17.00 | 129 | $2K | 1.9% |
| 20 | $17.01 | 400 | $7K | 6.0% |
| 21 | $17.02 | 200 | $3K | 3.0% |
| 22 | $17.03 | 100 | $2K | 1.5% |
| 23 | $17.05 | 300 | $5K | 4.5% |
| 24 | $17.06 | 100 | $2K | 1.5% |
| 25 | $17.07 | 300 | $5K | 4.5% |
| 26 | $17.08 | 100 | $2K | 1.5% |
| 27 | $17.09 | 300 | $5K | 4.5% |
| 28 | $17.10 | 400 | $7K | 6.0% |
| 29 | $17.12 | 100 | $2K | 1.5% |
| 30 | $17.13 | 300 | $5K | 4.5% |
| Total | $16.94 avg | 6,750 | $114K | 100% |
| Filing → |
| ALTU | SELL | 2007-03-26 | $50K | — | Filing → |
| ALTU | SELL | 2007-03-19 | $47K | — | Filing → |
| ALTU | SELL | 2007-03-06 | $44K | — | Filing → |